Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baer

Showing results (191-200 of 523) with videos related to

Pageof 53
Sort By:
Magma (New York, N.Y.)|November 6, 1998
Assessment of myocardial viability with MR--the Cologne perspectiveF M Baer, P Theissen, J Crnac, et al.
American Journal of Epidemiology|February 1, 1975
Determination of the site of oral rabies vaccinationG M Baer, J R Broderson, P A Yager
The Journal of Chemical Physics|March 4, 2006
Renner-Teller nonadiabatic coupling terms: An ab-initio study of the HNH moleculeG J Halász, A Vibók, R Baer, et al.
American Journal of Public Health|June 1, 1990
A survey of state regulation of testing for drugs of abuse outside of licensed (accredited) clinical laboratoriesD M Baer, R E Belsey, M R Skeels
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
An immunological determinant of RNase P protein is conserved between Escherichia coli and humansM J Mamula, M Baer, J Craft, et al.
The New England Journal of Medicine|August 9, 1979
Rabies diagnosis and rabies vaccineL J Anderson, W G Winkler, G M Baer
Zeitschrift Fur Kardiologie|August 7, 2001
[Recommendations for qualification in cardiovascular magnetic resonance tomography]U Sechtem, E Fleck, F M Baer, et al.
The Journal of Family Practice|September 1, 1991
An evaluation of a whole blood prothrombin analyzer designed for use by individuals without formal laboratory trainingR E Belsey, P M Fischer, D M Baer
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[Magnetic resonance tomography in coronary heart disease]U Sechtem, P Theissen, F M Baer, et al.
Blood Neoplasia|December 22, 2025
IgA or IgM MGUS less than 1.0 g/dL is at low risk of progression to neoplasmAshok P Pai, Lue-Yen Tucker, David M Baer
Pageof 53

Showing results (191-200 of 523) with videos related to

Sort By:
Pageof 53
Magma (New York, N.Y.)|November 6, 1998
Assessment of myocardial viability with MR--the Cologne perspectiveF M Baer, P Theissen, J Crnac, et al.
American Journal of Epidemiology|February 1, 1975
Determination of the site of oral rabies vaccinationG M Baer, J R Broderson, P A Yager
The Journal of Chemical Physics|March 4, 2006
Renner-Teller nonadiabatic coupling terms: An ab-initio study of the HNH moleculeG J Halász, A Vibók, R Baer, et al.
American Journal of Public Health|June 1, 1990
A survey of state regulation of testing for drugs of abuse outside of licensed (accredited) clinical laboratoriesD M Baer, R E Belsey, M R Skeels
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
An immunological determinant of RNase P protein is conserved between Escherichia coli and humansM J Mamula, M Baer, J Craft, et al.
The New England Journal of Medicine|August 9, 1979
Rabies diagnosis and rabies vaccineL J Anderson, W G Winkler, G M Baer
Zeitschrift Fur Kardiologie|August 7, 2001
[Recommendations for qualification in cardiovascular magnetic resonance tomography]U Sechtem, E Fleck, F M Baer, et al.
The Journal of Family Practice|September 1, 1991
An evaluation of a whole blood prothrombin analyzer designed for use by individuals without formal laboratory trainingR E Belsey, P M Fischer, D M Baer
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[Magnetic resonance tomography in coronary heart disease]U Sechtem, P Theissen, F M Baer, et al.
Blood Neoplasia|December 22, 2025
IgA or IgM MGUS less than 1.0 g/dL is at low risk of progression to neoplasmAshok P Pai, Lue-Yen Tucker, David M Baer
Pageof 53